Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: towards the "right" TIRADS.

Grani G, Lamartina L, Ascoli V, Bosco D, Biffoni M, Giacomelli L, Maranghi M, Falcone R, Ramundo V, Cantisani V, Filetti S, Durante C.

J Clin Endocrinol Metab. 2018 Oct 8. doi: 10.1210/jc.2018-01674. [Epub ahead of print]

PMID:
30299457
2.

Sonographically Estimated Risks of Malignancy for Thyroid Nodules Computed with Five Standard Classification Systems: Changes over Time and Their Relation to Malignancy.

Grani G, Lamartina L, Biffoni M, Giacomelli L, Maranghi M, Falcone R, Ramundo V, Cantisani V, Filetti S, Durante C.

Thyroid. 2018 Sep;28(9):1190-1197. doi: 10.1089/thy.2018.0178.

PMID:
30105949
3.

Sonographic Presentation of Metastases to the Thyroid Gland: A Case Series.

Falcone R, Ramundo V, Lamartina L, Ascoli V, Bosco D, Di Gioia C, Montesano T, Biffoni M, Bononi M, Giacomelli L, Minni A, Segni M, Maranghi M, Cantisani V, Durante C, Grani G.

J Endocr Soc. 2018 Jun 21;2(8):855-859. doi: 10.1210/js.2018-00124. eCollection 2018 Aug 1.

4.

Diagnostic accuracy of 3T magnetic resonance imaging in the preoperative localisation of parathyroid adenomas: comparison with ultrasound and 99mTc-sestamibi scans.

Argirò R, Diacinti D, Sacconi B, Iannarelli A, Diacinti D, Cipriani C, Pisani D, Romagnoli E, Biffoni M, Di Gioia C, Pepe J, Bezzi M, Letizia C, Minisola S, Catalano C.

Eur Radiol. 2018 May 7. doi: 10.1007/s00330-018-5437-8. [Epub ahead of print]

PMID:
29736849
5.

Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells.

Castiello L, Sestili P, Schiavoni G, Dattilo R, Monque DM, Ciaffoni F, Iezzi M, Lamolinara A, Sistigu A, Moschella F, Pacca AM, Macchia D, Ferrantini M, Zeuner A, Biffoni M, Proietti E, Belardelli F, Aricò E.

Cancer Immunol Res. 2018 Jun;6(6):658-670. doi: 10.1158/2326-6066.CIR-17-0675. Epub 2018 Apr 5.

PMID:
29622580
6.

Diagnosis and management of a mediastinal ectopic thyroid laying on the right bronchus: case report and review of literature.

Metere A, De Giacomo T, Vergine M, Biffoni M, Giacomelli L.

BMC Surg. 2018 Apr 4;18(1):19. doi: 10.1186/s12893-018-0354-y. Review.

7.

Colovesical fistula complicating diverticular disease: diagnosis and surgical management in elderly.

Biffoni M, Urciuoli P, Eberspacher C, Santoro A, Pironi D, Sorrenti S.

Minerva Chir. 2018 Mar 30. doi: 10.23736/S0026-4733.18.07723-4. [Epub ahead of print] No abstract available.

8.

Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs.

Grande S, Palma A, Ricci-Vitiani L, Luciani AM, Buccarelli M, Biffoni M, Molinari A, Calcabrini A, D'Amore E, Guidoni L, Pallini R, Viti V, Rosi A.

Stem Cells Int. 2018 Feb 18;2018:3292704. doi: 10.1155/2018/3292704. eCollection 2018.

9.

Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up.

Rosignolo F, Sponziello M, Giacomelli L, Russo D, Pecce V, Biffoni M, Bellantone R, Lombardi CP, Lamartina L, Grani G, Durante C, Filetti S, Verrienti A.

J Endocr Soc. 2017 Jan 12;1(1):3-13. doi: 10.1210/js.2016-1032. eCollection 2017 Jan 1.

10.

Two-Step Coimmunoprecipitation (TIP) Enables Efficient and Highly Selective Isolation of Native Protein Complexes.

Sciuto MR, Warnken U, Schnölzer M, Valvo C, Brunetto L, Boe A, Biffoni M, Krammer PH, De Maria R, Haas TL.

Mol Cell Proteomics. 2018 May;17(5):993-1009. doi: 10.1074/mcp.O116.065920. Epub 2017 Dec 7.

PMID:
29217617
11.

Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy.

Cerbelli B, Pisano A, Colafrancesco S, Pignataro MG, Biffoni M, Berni S, De Luca A, Riccieri V, Priori R, Valesini G, d'Amati G, Giordano C.

Virchows Arch. 2018 Mar;472(3):477-487. doi: 10.1007/s00428-017-2269-x. Epub 2017 Nov 16.

PMID:
29147923
12.

Cancer stem cells as functional biomarkers.

D'Andrea V, Panarese A, Tonda M, Biffoni M, Monti M.

Cancer Biomark. 2017 Sep 7;20(3):231-234. doi: 10.3233/CBM-151176. Review.

PMID:
28800308
13.

Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma.

Haas TL, Sciuto MR, Brunetto L, Valvo C, Signore M, Fiori ME, di Martino S, Giannetti S, Morgante L, Boe A, Patrizii M, Warnken U, Schnölzer M, Ciolfi A, Di Stefano C, Biffoni M, Ricci-Vitiani L, Pallini R, De Maria R.

Cell Stem Cell. 2017 Jul 6;21(1):35-50.e9. doi: 10.1016/j.stem.2017.04.009. Epub 2017 Jun 9.

14.

A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.

Marziali G, Buccarelli M, Giuliani A, Ilari R, Grande S, Palma A, D'Alessandris QG, Martini M, Biffoni M, Pallini R, Ricci-Vitiani L.

Mol Oncol. 2017 Sep;11(9):1115-1129. doi: 10.1002/1878-0261.12047. Epub 2017 Jul 13.

15.

The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response.

D'Alessandris QG, Biffoni M, Martini M, Runci D, Buccarelli M, Cenci T, Signore M, Stancato L, Olivi A, De Maria R, Larocca LM, Ricci-Vitiani L, Pallini R.

Neuro Oncol. 2017 Aug 1;19(8):1097-1108. doi: 10.1093/neuonc/now304.

16.

Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules.

Grani G, Lamartina L, Ascoli V, Bosco D, Nardi F, D'Ambrosio F, Rubini A, Giacomelli L, Biffoni M, Filetti S, Durante C, Cantisani V.

Endocrine. 2017 Aug;57(2):256-261. doi: 10.1007/s12020-016-1148-6. Epub 2016 Oct 31.

PMID:
27804016
17.

Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients.

Lamartina L, Montesano T, Trulli F, Attard M, Torlontano M, Bruno R, Meringolo D, Monzani F, Tumino S, Ronga G, Maranghi M, Biffoni M, Filetti S, Durante C.

Endocrine. 2016 Nov;54(2):467-475. Epub 2015 Dec 14.

PMID:
26668060
18.

Cripto is essential to capture mouse epiblast stem cell and human embryonic stem cell pluripotency.

Fiorenzano A, Pascale E, D'Aniello C, Acampora D, Bassalert C, Russo F, Andolfi G, Biffoni M, Francescangeli F, Zeuner A, Angelini C, Chazaud C, Patriarca EJ, Fico A, Minchiotti G.

Nat Commun. 2016 Sep 2;7:12589. doi: 10.1038/ncomms12589.

19.

Generation, Quantification, and Tracing of Metabolically Labeled Fluorescent Exosomes.

Coscia C, Parolini I, Sanchez M, Biffoni M, Boussadia Z, Zanetti C, Fiani ML, Sargiacomo M.

Methods Mol Biol. 2016;1448:217-35. doi: 10.1007/978-1-4939-3753-0_16.

PMID:
27317184
20.

UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response.

Signore M, Buccarelli M, Pilozzi E, De Luca G, Cappellari M, Fanciulli M, Goeman F, Melucci E, Biffoni M, Ricci-Vitiani L.

Oncotarget. 2016 Jul 12;7(28):44113-44128. doi: 10.18632/oncotarget.9859.

21.

Risk Stratification of Neck Lesions Detected Sonographically During the Follow-Up of Differentiated Thyroid Cancer.

Lamartina L, Grani G, Biffoni M, Giacomelli L, Costante G, Lupo S, Maranghi M, Plasmati K, Sponziello M, Trulli F, Verrienti A, Filetti S, Durante C.

J Clin Endocrinol Metab. 2016 Aug;101(8):3036-44. doi: 10.1210/jc.2016-1440. Epub 2016 May 17.

PMID:
27186860
22.

The true cost of thyroid surgery determined by a micro-costing approach.

Filetti S, Ladenson PW, Biffoni M, D'Ambrosio MG, Giacomelli L, Lopatriello S.

Endocrine. 2017 Feb;55(2):519-529. doi: 10.1007/s12020-016-0980-z. Epub 2016 May 12.

PMID:
27172916
23.

IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.

Buoncervello M, Romagnoli G, Buccarelli M, Fragale A, Toschi E, Parlato S, Lucchetti D, Macchia D, Spada M, Canini I, Sanchez M, Falchi M, Musella M, Biffoni M, Belardelli F, Capone I, Sgambato A, Vitiani LR, Gabriele L.

Oncotarget. 2016 May 3;7(18):26361-73. doi: 10.18632/oncotarget.8379.

24.

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome.

Marziali G, Signore M, Buccarelli M, Grande S, Palma A, Biffoni M, Rosi A, D'Alessandris QG, Martini M, Larocca LM, De Maria R, Pallini R, Ricci-Vitiani L.

Sci Rep. 2016 Feb 9;6:21557. doi: 10.1038/srep21557.

25.

Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.

D'Ambrosio A, Cossu A, Amendola A, Zandri A, Butera A, Sanchez M, Biffoni M, Pronio A, Montesani C, Kohn A, Pica R, Boirivant M.

J Crohns Colitis. 2016 Mar;10(3):346-53. doi: 10.1093/ecco-jcc/jjv216. Epub 2015 Nov 20.

26.

miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.

Lulli V, Buccarelli M, Martini M, Signore M, Biffoni M, Giannetti S, Morgante L, Marziali G, Ilari R, Pagliuca A, Larocca LM, De Maria R, Pallini R, Ricci-Vitiani L.

Oncotarget. 2015 Nov 10;6(35):37241-56. doi: 10.18632/oncotarget.5925.

27.

Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancers.

Dima M, Pecce V, Biffoni M, Di Gioia CR, Tallini G, Biffoni M, Rosignolo F, Verrienti A, Sponziello M, Damante G, Russo D, Durante C.

Endocrine. 2016 Jul;53(1):145-56. doi: 10.1007/s12020-015-0739-y. Epub 2015 Sep 14.

PMID:
26370117
28.

The MUTYH base excision repair gene protects against inflammation-associated colorectal carcinogenesis.

Grasso F, Di Meo S, De Luca G, Pasquini L, Rossi S, Boirivant M, Biffoni M, Bignami M, Di Carlo E.

Oncotarget. 2015 Aug 14;6(23):19671-84.

29.

Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.

Shytaj IL, Nickel G, Arts E, Farrell N, Biffoni M, Pal R, Chung HK, LaBranche C, Montefiori D, Vargas-Inchaustegui D, Robert-Guroff M, Lewis MG, Sacha JB, Palamara AT, Savarino A.

J Virol. 2015 Aug;89(15):7521-35. doi: 10.1128/JVI.00396-15. Epub 2015 May 13.

30.

Glioblastoma stem cells: radiobiological response to ionising radiations of different qualities.

Pecchia I, Dini V, Ricci-Vitiani L, Biffoni M, Balduzzi M, Fratini E, Belli M, Campa A, Esposito G, Cirrone G, Romano F, Stancampiano C, Pelacchi F, Pallini R, Tabocchini MA.

Radiat Prot Dosimetry. 2015 Sep;166(1-4):374-8. doi: 10.1093/rpd/ncv299. Epub 2015 May 11.

PMID:
25969527
31.

(1) H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness.

Rosi A, Ricci-Vitiani L, Biffoni M, Grande S, Luciani AM, Palma A, Runci D, Cappellari M, De Maria R, Guidoni L, Pallini R, Viti V.

NMR Biomed. 2015 Mar;28(3):317-26. doi: 10.1002/nbm.3254. Epub 2015 Jan 8.

PMID:
25581615
32.

miR-21 is overexpressed in NPM1-mutant acute myeloid leukemias.

Riccioni R, Lulli V, Castelli G, Biffoni M, Tiberio R, Pelosi E, Lo-Coco F, Testa U.

Leuk Res. 2015 Feb;39(2):221-8. doi: 10.1016/j.leukres.2014.11.001. Epub 2014 Nov 18.

PMID:
25543261
33.

Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer.

Zeuner A, Francescangeli F, Contavalli P, Zapparelli G, Apuzzo T, Eramo A, Baiocchi M, De Angelis ML, Biffoni M, Sette G, Todaro M, Stassi G, De Maria R.

Cell Death Differ. 2014 Dec;21(12):1877-88. doi: 10.1038/cdd.2014.105. Epub 2014 Jul 18.

34.

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.

Signore M, Pelacchi F, di Martino S, Runci D, Biffoni M, Giannetti S, Morgante L, De Majo M, Petricoin EF, Stancato L, Larocca LM, De Maria R, Pallini R, Ricci-Vitiani L.

Cell Death Dis. 2014 May 8;5:e1223. doi: 10.1038/cddis.2014.188.

35.

CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.

Todaro M, Gaggianesi M, Catalano V, Benfante A, Iovino F, Biffoni M, Apuzzo T, Sperduti I, Volpe S, Cocorullo G, Gulotta G, Dieli F, De Maria R, Stassi G.

Cell Stem Cell. 2014 Mar 6;14(3):342-56. doi: 10.1016/j.stem.2014.01.009.

36.

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.

Bartucci M, Dattilo R, Moriconi C, Pagliuca A, Mottolese M, Federici G, Benedetto AD, Todaro M, Stassi G, Sperati F, Amabile MI, Pilozzi E, Patrizii M, Biffoni M, Maugeri-Saccà M, Piccolo S, De Maria R.

Oncogene. 2015 Feb 5;34(6):681-90. doi: 10.1038/onc.2014.5. Epub 2014 Feb 17.

PMID:
24531710
37.

Antitumor effect of miR-197 targeting in p53 wild-type lung cancer.

Fiori ME, Barbini C, Haas TL, Marroncelli N, Patrizii M, Biffoni M, De Maria R.

Cell Death Differ. 2014 May;21(5):774-82. doi: 10.1038/cdd.2014.6. Epub 2014 Jan 31.

38.

Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.

D'Agostino M, Sponziello M, Puppin C, Celano M, Maggisano V, Baldan F, Biffoni M, Bulotta S, Durante C, Filetti S, Damante G, Russo D.

J Mol Endocrinol. 2014 Jan 30;52(2):121-31. doi: 10.1530/JME-13-0160. Print 2014 Apr.

PMID:
24353283
39.

Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts.

Sette G, Fecchi K, Salvati V, Lotti F, Pilozzi E, Duranti E, Biffoni M, Pagliuca A, Martinetti D, Memeo L, Milella M, De Maria R, Eramo A.

J Exp Clin Cancer Res. 2013 Nov 16;32:91. doi: 10.1186/1756-9966-32-91.

40.

1H NMR detects different metabolic profiles in glioblastoma stem-like cells.

Guidoni L, Ricci-Vitiani L, Rosi A, Palma A, Grande S, Luciani AM, Pelacchi F, di Martino S, Colosimo C, Biffoni M, De Maria R, Pallini R, Viti V.

NMR Biomed. 2014 Feb;27(2):129-45. doi: 10.1002/nbm.3044. Epub 2013 Oct 21.

PMID:
24142746
41.

Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy.

Todaro M, Turdo A, Bartucci M, Iovino F, Dattilo R, Biffoni M, Stassi G, Federici G, De Maria R, Zeuner A.

Cancer Res. 2013 Nov 1;73(21):6393-400. doi: 10.1158/0008-5472.CAN-13-0248. Epub 2013 Sep 5.

42.

BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.

Gabellini C, De Luca T, Trisciuoglio D, Desideri M, Di Martile M, Passeri D, Candiloro A, Biffoni M, Rizzo MG, Orlandi A, Del Bufalo D.

Carcinogenesis. 2013 Nov;34(11):2558-67. doi: 10.1093/carcin/bgt242. Epub 2013 Jul 8.

PMID:
23836782
43.

Management of acute clinical presentation of anaplastic thyroid cancer. A difficult choice.

Biffoni M, Garritano S, Scipioni P, Colangelo M, De Meo D, Monti M.

Ann Ital Chir. 2013 Mar-Apr;84(2):187-91.

PMID:
23698085
44.

Duodenal tumors: four case reports.

Pasta V, Biffoni M, Martino G, Malavenda MS, Sottile D, Marinaccio L, Merola R, Vergine M, Bernieri MG, Monti M, Redler A.

G Chir. 2013 Mar;34(3):74-7.

PMID:
23578410
45.

miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma.

Felli N, Felicetti F, Lustri AM, Errico MC, Bottero L, Cannistraci A, De Feo A, Petrini M, Pedini F, Biffoni M, Alvino E, Negrini M, Ferracin M, Mattia G, Carè A.

PLoS One. 2013;8(2):e56824. doi: 10.1371/journal.pone.0056824. Epub 2013 Feb 21.

46.

Human haemato-endothelial precursors: cord blood CD34+ cells produce haemogenic endothelium.

Pelosi E, Castelli G, Martin-Padura I, Bordoni V, Santoro S, Conigliaro A, Cerio AM, De Santis Puzzonia M, Marighetti P, Biffoni M, Alonzi T, Amicone L, Alcalay M, Bertolini F, Testa U, Tripodi M.

PLoS One. 2012;7(12):e51109. doi: 10.1371/journal.pone.0051109. Epub 2012 Dec 4.

47.

DNA damage response in monozygotic twins discordant for smoking habits.

Marcon F, Carotti D, Andreoli C, Siniscalchi E, Leopardi P, Caiola S, Biffoni M, Zijno A, Medda E, Nisticò L, Rossi S, Crebelli R.

Mutagenesis. 2013 Mar;28(2):135-44. doi: 10.1093/mutage/ges062. Epub 2012 Nov 6.

PMID:
23132286
48.

Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression.

Pagliuca A, Valvo C, Fabrizi E, di Martino S, Biffoni M, Runci D, Forte S, De Maria R, Ricci-Vitiani L.

Oncogene. 2013 Oct;32(40):4806-13. doi: 10.1038/onc.2012.495. Epub 2012 Nov 5.

PMID:
23128394
49.

EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential.

Sette G, Salvati V, Memeo L, Fecchi K, Colarossi C, Di Matteo P, Signore M, Biffoni M, D'Andrea V, De Antoni E, Canzonieri V, De Maria R, Eramo A.

PLoS One. 2012;7(10):e46891. doi: 10.1371/journal.pone.0046891. Epub 2012 Oct 8.

50.

Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells.

Francescangeli F, Patrizii M, Signore M, Federici G, Di Franco S, Pagliuca A, Baiocchi M, Biffoni M, Ricci Vitiani L, Todaro M, De Maria R, Zeuner A.

Stem Cells. 2012 Sep;30(9):1819-30. doi: 10.1002/stem.1163.

Supplemental Content

Loading ...
Support Center